|
Jul 31
|
Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology
|
|
Jul 31
|
Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
|
|
Jul 30
|
Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
|
|
Jul 25
|
Stocks to watch next week: Microsoft, Apple, Shell, AstraZeneca and HSBC
|
|
Jul 23
|
Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast
|
|
Jul 23
|
Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know
|
|
Jul 23
|
Stocks making big moves yesterday: Vital Farms, Robinhood, Simmons First National, Medpace, and Azenta
|
|
Jul 22
|
Why Azenta (AZTA) Stock Is Up Today
|
|
Jul 18
|
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know
|
|
Jul 18
|
Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks
|
|
Jul 17
|
Q1 Earnings Outperformers: Azenta (NASDAQ:AZTA) And The Rest Of The Drug Development Inputs & Services Stocks
|
|
Jun 18
|
Shareholders in Azenta (NASDAQ:AZTA) have lost 59%, as stock drops 3.6% this past week
|
|
Apr 24
|
Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast
|
|
Jan 20
|
Bullish Azenta Insiders Loaded Up On US$1.29m Of Stock
|
|
Dec 30
|
Azenta (NASDAQ:AZTA) shareholders have endured a 51% loss from investing in the stock three years ago
|
|
Jul 24
|
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast
|
|
May 13
|
Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK
|
|
May 10
|
Azenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges
|
|
May 8
|
Azenta Announces CEO Succession Plan
|
|
May 8
|
Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024
|